Concepedia

Radionuclide Therapy

Radionuclide therapy is a form of internal radiation therapy that utilizes radioactive pharmaceutical agents administered to the body to deliver localized therapeutic doses of ionizing radiation to target tissues or malignant cells.

13.1K

Publications

629.7K

Citations

44.7K

Authors

5.6K

Institutions

Publications per year

2017–2026

2.4K

Variants

Molecular Radiotherapy

Parents

Children

Publications

13.1K

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

W. M. Hunter, F. C. Greenwood · Nature · 1962 · 7K citations

, , +14

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Chris Parker, Sten Nilsson, Daniel Heinrich et al. · New England Journal of Medicine · 2013 · 3.3K citations

, , +17

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Oliver Sartor, Johann S. de Bono, Kim N. et al. · New England Journal of Medicine · 2021 · 2.6K citations · Full text

, , +17

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

Martin Schlumberger, Makoto Tahara, Lori J. Wirth et al. · New England Journal of Medicine · 2015 · 2.1K citations · Full text

, , +13

Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy

Cosimo Durante, Nadia Haddy, E. Baudin et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 1.7K citations

, , +17

1–5 of 13.1K

Authors

44.7K

  1. DM
    David M. Goldenberg

    Center for Molecular Medicine and Immunology, United States

    107 publications · 6.2K citations

    50

    h-index

  2. EP
    Eric P. Krenning

    Erasmus MC, Netherlands

    73 publications · 9.5K citations

    48

    h-index

  3. MD
    Marion de Jong

    Erasmus MC, Netherlands

    78 publications · 6.7K citations

    47

    h-index

  4. SM
    Steven M. Larson

    Memorial Sloan Kettering Cancer Center, United States

    73 publications · 7.5K citations

    46

    h-index

  5. MW
    Martin W. Brechbiel

    National Cancer Institute, United States

    71 publications · 4.3K citations

    45

    h-index

1–5 of 44.7K

Institutions

5.6K

  1. Memorial Sloan Kettering Cancer Center

    New York, United States

    93 h-index

    1.2K publications

    110.6K citations

  2. Erasmus MC

    Rotterdam, The Netherlands

    66 h-index

    662 publications

    74.1K citations

  3. National Institutes of Health

    Bethesda, United States

    61 h-index

    541 publications

    36.3K citations

  4. Johns Hopkins University

    Baltimore, United States

    61 h-index

    686 publications

    46.4K citations

  5. Erasmus University Rotterdam

    Rotterdam, The Netherlands

    58 h-index

    570 publications

    53.1K citations

  6. Cornell University

    Ithaca, United States

    57 h-index

    588 publications

    94.4K citations

  7. National Cancer Institute

    Bethesda, United States

    57 h-index

    477 publications

    28.3K citations

  8. Heidelberg University

    Heidelberg, Germany

    56 h-index

    520 publications

    50.4K citations

1–8 of 5.6K

Venues

  1. PubMed

    Repository · 1.9K publications · 89.5K citations

    127

    h-index

  2. 96

    h-index

  3. The Journal of Clinical Endocrinology & Metabolism

    JCEM · 436 publications · 30.8K citations

    94

    h-index

  4. Journal of Nuclear Medicine

    376 publications · 28.8K citations

    91

    h-index

  5. 69

    h-index

1–5

See also

Radionuclide Therapy

Radioisotopes

Dosimetry

Targeting Agents

Clinical Indications

Toxicities